Patent foramen ovale closure for cryptogenic stroke: Effective, but only in select patients

Catheter Cardiovasc Interv. 2018 Jul;92(1):174-175. doi: 10.1002/ccd.27700.

Abstract

PFO closure reduces risk of recurrent stroke in some patients with cryptogenic stroke, particularly younger patients <45 years with moderate or greater right to left shunting Number needed to treat (NNT) to prevent one stroke at 5 years are 28 to 69 (95% confidence limits of 21 to 351) suggesting need for individualized risk stratification models PFO closure may increase short- and possibly long-term risk of atrial flutter/fibrillation.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Atrial Fibrillation*
  • Foramen Ovale, Patent*
  • Humans
  • Randomized Controlled Trials as Topic
  • Secondary Prevention
  • Stroke*